Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1994-10-25
1997-06-03
Scheiner, Toni R.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 724, 435 71, 435 72, 435961, 436 63, 436 64, 436813, G01N 33574, G01N 3353
Patent
active
056353618
ABSTRACT:
A tumor-mimetic cell surface antigen (TMCSA) is produced by chemical treatment of normal human cells with fluordinitrobenzene. This TMCSA cross-reacts with tumor antigens from every type of tumor examined of any histopathologic type. Cancer is detected by detecting the presence of lymphocytes sensitized to tumor antigens based on their reactivity with TMCSA in a binding assay or lymphocyte stimulation assay.
REFERENCES:
patent: 3663684 (1972-05-01), Freedman et al.
patent: 4132776 (1979-01-01), Jeter
patent: 4211766 (1980-07-01), Bjorklund
patent: 5030621 (1991-07-01), Bystryn
patent: 5290551 (1994-03-01), Berd
Iyer et al., "A Model Study for Determining the Mechanism of Exposure of Leukemia-specific Antigen on Dinitrophenylated Leukocytes, " Indian Journal of Biochemistry & Biophysics (1979) 16:110-114.
Karande et al., "Isolation of Leukemia specific antigenic macromolecular moiety from dinitrophenylated normal human leukocytes," Proc. Indian Acad. Sci., (1978) vol. 87B(1):1-8.
Mehrishi et al., "Positively Charged Amino Groups on the Surface of Normal and Cancer Cells," Europ. J. Cancer (1970) 6:127-137.
Prema et al, "Immunological cross-reactivity of antisera raised with fluoro diniro benzyne tagged normal human leukocytes against human leukaemic cells," Ind. J. Cancer (1978) 15:53-57.
Prema et al., "Electrophoretic mobility of (a) normal human leukocytes, (b) fluorodinitrobenzene tagged normal human leukocytes and (c) human leukaemic cells," Ind. J. Cancer (1977) 14:200-205.
Sahasrabudhe, et al., "Two-Fold Strategy in Cancer Research for Achieving (a) Lasting Cures From Cancer By Reversal of Malignant Cells of Normality and (b) Securing Immediate Interim Reliefs for Patients, " Ind. J. Cancer (1968) 5:217-228.
Sahasrabudhe, "Role of Immunology in the Management of Leukemia, " Aspects of Allergy and Applied Immunology (1973) 6:16-29.
Sahasrabudhe et al., "Some observations on the use of chemically laelled normal white blood cells as antigens in active immunizationof leukaemia, " Biomedicine (1974) 20:31-39.
Sahasrabudhe et al., "Studies on the Use of Cemically Tagged Normal White Blood Bells as Antigens for Producing Specific Immune response Against Human Leukemic Cells, " The Indian Journal of Cancer (1972) 9(2):101-111.
Sahasrabudhe et al., "Development of a Specific Anti-Leukaemic Serum for the Treatment of Leukaemia in Clinics, " Nature (1971) 232:197-198.
Sahasrabudhe et al., "Induction of Specific Autoimmune Response to Leukaemic Cells in Human Leukaemia Patient by Chemically Tagged Normal `O` Group White Blood Cells, " Nature (1971) 232:198-199.
Sahasrabudhe et al., "Modification of Cell Surface Receptors/Antigens by In Situ Hydrophilic-Hydrophobic Interconversions, with Special Reference to Exposure of Tumor Specific Antigens on Normal Cell Surfaces, " Biology of the Cancer Cell, Proceedings of the Fifth Meeting of the European Associaion for Cancer Research, Vienna 9-12 Sep. 1979, pp. 241-252.
LandOfFree
Diagnosis of cancer using tumor-mimetic cell surface antigen fro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis of cancer using tumor-mimetic cell surface antigen fro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of cancer using tumor-mimetic cell surface antigen fro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-390596